Business Wire

SIGFOX

Share
Condat Introduces IoT on Tunnel Boring Sites Thanks to delaware and Sigfox

Condat, a global specialist in surface chemistry including industrial lubricants, today announced its partnership with Sigfox, the world's leading IoT service provider and initiator of the 0G network. With its long-term partner delaware, an internationally renowned integrator of innovative technology solutions, the two companies have created CondatLink, an IoT solution capable of helping tunnel boring machine operators to better manage their supply and stock of sealant on construction sites.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200701005389/en/

Sealant stock management: a major challenge for tunnel construction

With more than 25 years of experience in the field of tunnels, with more than 4,500 km laid, Condat has unique know-how and an international reputation in its sector. In particular, the company is a leader in the manufacture and supply of tail seal greases, products designed for tunnel construction in wet areas. Tail seal greases are essential for tunnelling especially in the event of water ingress, as job sites risk being delayed and, in the worst case, may even be submerged.

Condat delivers all over the world using 20-ton containers. Until now Condit’s sales teams worked with customers to estimate requirements, without being able to obtain precise information on sealant consumption.

"We needed a solution to prevent our tunnel boring machine customers from running out of sealant on their sites. In the life of a construction site, many parameters can speed up or slow down the consumption of this product. To satisfy our customers, we had to think of a way to find out about it, without having to contact someone on the worksites. We had the feeling that IoT was the right way to go, so we turned to delaware, our technology solutions partner of more than 23 years, to help us," explains Guy Chemisky, Director of Operations at Condat.

CondatLink started as a concept last November at Del20, the delaware working group focused on innovation, where concrete cases and feedback are shared, and in January, the project was launched:

"We started this project together by working on an end-to-end strategy: from the ideas phase to the design of the applications. We then put several people from the IoT ecosystem in touch with each other. Sigfox was chosen to support us during the implementation of this project and the design of the tracking and monitoring equipment," adds Baptiste Duriez, Partner at delaware.

Sigfox was chosen by Condat for its 0G network covering more than 70 countries and regions and its proposal to fully integrate the solution into Condat's SAP environment.

"We were very delighted by the maturity of the thinking. The Condat and delaware teams had carried out an in-depth study of the service experience expected for users and how the solution would fit into production. Even the notion of return on investment with stock management had been analysed. We were therefore able to bring our expertise to the project to introduce a solution very quickly," says Patrick Cason, Managing Director of Sigfox France.

"This project was carried out thanks to a dozen-strong team from Condat, delaware and Sigfox. By combining all these skills, the spirit of innovating together and the desire to co-develop with our suppliers, we managed to finalize this project in a very short timeframe and in the middle of a period of lockdown," adds Guy Chemisky.

The IoT for better consumption monitoring on construction sites

Sigfox's expertise has led to the implementation of the CondatLink solution, which will be available internationally and will enable more precise information about the level of consumption of sealant on building sites, thanks to a connected device that monitors the opening and closing of sealant drums.

The device is attached to the drums as soon as they leave the production plant. It is small (116x45x30mm), light (around 100g) and has, at least, a one-year battery life. As for the software, it uses Sigfox Monarch (international device, frequency management) and Atlas (geolocation) technologies. It will emit a message regularly to signal the location of the drum (asset tracking) while emitting regular messages indicating its change of state when the drum is opened (asset monitoring).

The information obtained by this connected device is sent to Condat and their clients via the Sigfox 0G network and available on a dedicated tracking application. This platform will take the form of a dashboard allowing the customer to track consumption and stock, and Condat to manage its deliveries worldwide.

Aware of environmental issues, Condat has been offering solutions for more than 20 years that are more respectful of individuals and the planet. The development of CondatLink is part of this approach. Thus, with delaware and Sigfox, Condat wanted to pay particular attention to the ecodesign and optimization of the battery. Moreover, the optimisation of transport and the better planning of deliveries, obtained via this solution, enable the company to avoid air transport as much as possible and, therefore, to greatly reduce carbon footprint.

A first use case that aims to deploy tens of thousands of connected objects

A test phase is planned for July with the implementation of this solution over two sites. Initially, the challenge will be the deployment of tens of thousands of objects by next year.

"Tomorrow, we will be able to go further than just monitoring the consumption of sealant on building sites. It will be possible to do this with many other products and for sectors other than tunnel builders. One of our major technological challenges in the coming years will be to make greater use of the data we have been collecting for more than 20 years to build predictive models and serve our customers better ," concludes Guy Chemisky.

About Sigfox

Sigfox is the initiator of the 0G network and the world’s leading IoT (Internet of Things) service provider. Its global network allows billions of devices to connect to the Internet, in a straightforward way, while consuming as little energy as possible. Sigfox’s unique approach to device-to-cloud communications addresses the three greatest barriers to global IoT adoption: cost, energy consumption and global scalability.

Today, the network is available in 70+ countries, with 1 billion people covered. ISO 9001 certified and surrounded by a large ecosystem of partners and IoT key players, Sigfox empowers companies to move their business model towards more digital services, in key areas such as Asset Tracking and Supply Chain. Founded in 2010 by Ludovic Le Moan and Christophe Fourtet, the company is headquartered in France and has offices in Madrid, Munich, Boston, Dallas, San Jose, Dubai, Singapore, Sao Paulo and Tokyo.

About Condat

Condat, an independent international group of French origin, formulates and manufactures a complete range of lubricants and special chemicals for the world of industry.

With proven technical and sales expertise over 160 years, the CONDAT group offers one of the widest ranges on the market, and knows how to satisfy the requirements of many fields of application: wire drawing, tunnel boring, forging, glass, machining, industrial maintenance...

CONDAT recommends to its customers the best lubrication solution from a technical and economical point of view, while taking into account environmental and safety issues.

Leader in tunnelling:

Since 1989, Condat has been developing a complete range of products, lubricants and additives meeting the technical, safety and environmental requirements of underground works such as : tails seal greases, main bearing tail seal greases, hydraulic fluids, foaming agents and polymers, additives for ground treatment... CONDAT, worldwide leader on this application, offers a complete range of biodegradable and fire resistant products dedicated to this market. With the support of a dedicated team of experts and complete services (training, advice...), CONDAT does its utmost to support tunnel specialists whatever the type of tunnel boring machine and the constraints of the construction site.

About delaware

delaware is a global company that delivers advanced ICT solutions and services, recognized on the French market and internationally, delaware helps companies in the daily use of their information system, thanks to its 350 experts based in Lyon, Lille, Nantes, Paris, and Bordeaux. delaware is an internationally renowned company, present in 12 countries with 24 offices.

delaware guides its clients throughout the transformation of their business by relying on its local agencies and deploying the solutions of its main business partners SAP & Microsoft.

Business transformation, next-gen applications, customer connection, data and analysis, applied innovations, information management, maintenance, training: delaware supports its customers in their digital transformation thanks to the most innovative technologies (next-gen erp, artificial intelligence, blockchain, cloud, intelligent applications, IoT, virtual and augmented reality, chatbot, etc.), particularly in the retail, food and beverage, automotive, engineering and professional services industries.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 13:00:00 CEST | Press release

– Vimseltinib demonstrated statistically significant and clinically meaningful benefit vs placebo in antitumor response – Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the dura

ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 16:09:00 CEST | Press release

ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui

Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 16:00:00 CEST | Press release

With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2%Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary endpoints including pain and functionApplication for marketing authorization under review by China National Medical Products Administration (NMPA), with additional applications planned in the U.S. and other marketsNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the stud

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 15:04:00 CEST | Press release

- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Second pivotal development program of povetacicept underway with Phase 2b/3 trial initiation in primary membranous nephropathy - - Updated data from RUBY-3 trial of povetacicept accepted for late breaking oral presentation; inaxaplin study design and APOL1-mediated kidney disease related data accepted for poster presentation - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B c

Qualcomm Announces Quarterly Cash Dividend17.10.2025 15:00:00 CEST | Press release

Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye